KLK3 and prostate carcinoma: The purpose of this study was to validate the detection of clinically significant prostate cancer in patients with serum PSA > 4.0 ng/ml by PI-RADS v2 and to assess the ability of quantitative MRI parameters to both detect and grade clinically significant prostate cancer in an Indian demographic.